Skip to main content
. 2016 Jul 18;7(33):53628–53641. doi: 10.18632/oncotarget.10682

Table 3. Expression of glutamine metabolism-related proteins according to the histologic subtype and BRAF V600E mutation status of papillary thyroid carcinoma.

Parameters Total
N=344 (%)
Histologic subtype p-value BRAF V600E mutation status p-value
Conventional type
n= 304 (%)
Follicular variant
n= 40 (%)
No mutation
n= 106 (%)
Mutation
n= 238 (%)
GLS1 (T) 0.024 <0.001
 Negative 141 (41.0) 118 (38.8) 23 (57.5) 58 (54.7) 83 (34.9)
 Positive 203 (59.0) 186 (61.2) 17 (42.5) 48 (45.3) 155 (65.1)
GDH (T) <0.001 <0.001
 Negative 43 (12.5) 28 (9.2) 15 (37.5) 26 (24.5) 17 (7.1)
 Positive 301 (87.5) 276 (90.8) 25 (62.5) 80 (75.5) 221 (92.9)
GDH (S) 1.000 0.246
 Negative 341 (99.1) 301 (99.0) 40 (100.0) 106 (100.0) 235 (98.7)
 Positive 3 (0.9) 3 (1.0) 0 (0.0) 0 (0.0) 3 (1.3)
ASCT2 (T) 0.041 <0.001
 Negative 289 (84.0) 251 (82.6) 38 (95.0) 102 (96.2) 187 (78.6)
 Positive 55 (16.0) 53 (17.4) 2 (5.0) 4 (3.8) 51 (21.4)

GLS1; glutaminase 1, GDH; glutamate dehydrogenase, ASCT2; amino acid transporter-2